Patents by Inventor Stephen Rattigan

Stephen Rattigan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and pharmaceuticals for treating muscle insulin resistance and related conditions
    Publication number: 20080019916
    Abstract: A method of screening compounds for the ability to increase capillary blood flow, the method comprising: (a) taking a first measurement of capillary blood flow in a subject; (b) administering a compound to said subject; (c) taking a second measurement of capillary blood flow in said subject, and (d) comparing said first and second measurements, wherein a positive difference between said first and second measurements indicate the ability of said compound to increase capillary blood flow.
    Type: Application
    Filed: July 6, 2007
    Publication date: January 24, 2008
    Applicant: University of Tasmania
    Inventors: Michael Clark, Stephen Rattigan
  • Method and measuring changes in microvascular capillary blood flow
    Publication number: 20050049507
    Abstract: A method of measuring changes in microvascular capillary flow in a predetermined region in a subject comprising: (a) administering an ultrasound contrast medium to said subject such that said contrast medium reaches the microvascular capillaries in said predetermined region; (b) measuring microvascular capillary blood flow volume and/or microvascular flow index of said capillaries; (c) applying a defined signal to said subject; and, (d) measuring changes in said microvascular capillary flow.
    Type: Application
    Filed: June 11, 2002
    Publication date: March 3, 2005
    Inventors: Michael Clark, Stephen Rattigan, Eugene Barret, Jonathan Lindner, Sanjiv Kaul
  • Methods and pharmaceuticals for treating muscle insulin resistance and related conditions
    Publication number: 20040197265
    Abstract: The present invention relates to methods and drugs for ameliorating insulin resistance in skeletal muscle, a major contributing abnormality to impaired glucose handling in such diseases as type 1 and type 2 diabetes, hypertension, obesity and critical care patients. This invention provides drugs, methods for screening those drugs and methods specifically targeted to ameliorating insulin resistance by increasing capillary blood flow in muscle.
    Type: Application
    Filed: May 14, 2004
    Publication date: October 7, 2004
    Inventors: Michael Clark, Stephen Rattigan